Lactobacillus plantarum NA136 ameliorates nonalcoholic fatty liver disease by modulating gut microbiota, improving intestinal barrier integrity, and attenuating inflammation (original) (raw)

References

• Abu-Shanab A, Quigley EMM (2010) The role of the gut microbiota in nonalcoholic fatty liver disease. Nat Rev Gastroenterol Hepatol 7(12):691–701. https://doi.org/10.1038/nrgastro.2010.172
  Article PubMed Google Scholar
• Byrne CD (2010) Fatty liver: role of inflammation and fatty acid nutrition. Prostaglandins, leukotrienes and essential fatty acids (PLEFA) 82(4–6):265–271. https://doi.org/10.1016/j.plefa.2010.02.012
  Article CAS Google Scholar
• Byrne CD, Targher G (2015) NAFLD: a multisystem disease. J Hepatol 62(1):S47–S64. https://doi.org/10.1016/j.jhep.2014.12.012
  Article PubMed Google Scholar
• Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R (2010) QIIME allows analysis of high-throughput community sequencing data. Nat Methods 7(5):335–336. https://doi.org/10.1038/nmeth.f.303
  Article CAS PubMed PubMed Central Google Scholar
• Caussy C, Loomba R (2018) Gut microbiome, microbial metabolites and the development of NAFLD. Nat Rev Gastroenterol Hepatol 15:719–720. https://doi.org/10.1038/s41575-018-0058-x
  Article PubMed Google Scholar
• Caussy C, Tripathi A, Humphrey G, Bassirian S, Singh S, Faulkner C, Bettencourt R, Rizo E, Richards L, Xu ZZ, Downes MR, Evans RM, Brenner DA, Sirlin CB, Knight R, Loomba R (2019) A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease. Nat Commun 10(1):1406. https://doi.org/10.1038/s41467-019-09455-9
  Article CAS PubMed PubMed Central Google Scholar
• Cesaro C, Tiso A, Prete AD, Cariello R, Tuccillo C, Cotticelli G, Blanco CV, Loguercio C (2011) Gut microbiota and probiotics in chronic liver diseases. Dig Liver Dis 43(6):431–438. https://doi.org/10.1016/j.dld.2010.10.015
  Article PubMed Google Scholar
• Chatelier EL, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, Leonard P, Li J, Burgdorf K, Grarup N, Jørgensen T, Brandslund I, Nielsen HB, Juncker AS, Bertalan M, Levenez F, Pons N, Rasmussen S, Sunagawa S, Tap J, Tims S, Zoetendal EG, Brunak S, Clément K, Doré J, Kleerebezem M, Kristiansen K, Renault P, Sicheritz-Ponten T, de Vos WM, Zucker JD, Raes J, Hansen T, Consortium M, Bork P, Wang J, Ehrlich SD, Pedersen O (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500(7464):541–546. https://doi.org/10.1038/nature12506
  Article CAS PubMed Google Scholar
• Chen YH, Yu Z, Fu L, Wang H, Wang H, Chen X, Zhang C, Lv ZM, Xu DX (2015) Vitamin D3 inhibits lipopolysaccharide-induced placental inflammation through reinforcing interaction between vitamin D receptor and nuclear factor kappa B p65 subunit. Sci Rep 5:10871. https://doi.org/10.1038/srep10871
  Article CAS PubMed PubMed Central Google Scholar
• Chen Y, Jin L, Li Y, Xia G, Chen C, Zhang Y (2018) Bamboo-shaving polysaccharide protects against high-diet induced obesity and modulates the gut microbiota of mice. J Funct Foods 49:20–31. https://doi.org/10.1016/j.jff.2018.08.015
  Article CAS Google Scholar
• Compare D, Coccoli P, Rocco A, Nardone OM, De Maria S, Cartenì M, Nardone G (2012) Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutr Metab Cardiovasc Dis 22(6):471–476. https://doi.org/10.1016/j.numecd.2012.02.007
  Article CAS PubMed Google Scholar
• Duan C, Zhao Y, Huang C, Zhao Z, Gao L, Niu C, Wang C, Liu X, Zhang C, Li S (2018) Hepatoprotective effects of Lactobacillus plantarum C88 on LPS/D-GalN–induced acute liver injury in mice. J Funct Foods 43:146–153. https://doi.org/10.1016/j.jff.2018.02.005
  Article CAS Google Scholar
• Eslamparast T, Eghtesad S, Hekmatdoost A, Poustchi H (2013) Probiotics and nonalcoholic fatty liver disease. Middle East J Dig Dis 5(3):129–136. https://doi.org/10.15171/middle%20east%20j%20di.v5i3.1199
  Article PubMed PubMed Central Google Scholar
• Fan JG, Farrell GC (2009) Epidemiology of non-alcoholic fatty liver disease in China. J Hepatol 50(1):204–210. https://doi.org/10.1016/j.jhep.2008.10.010
  Article PubMed Google Scholar
• Fang S, Wu D, Yang Z, Jiao N, Lin Y, Li X, Xiao J, Yuan M, Zhu R, Zhu L (2019) Keystone species in the pathogenic process of NAFLD. FASEB J 33(1_supplement):496.40. https://doi.org/10.1096/fasebj.2019.33.1_supplement.496.40
  Article Google Scholar
• Figliuolo VR, Coutinho-Silva R, Coutinho CMLM (2018) Contribution of sulfate-reducing bacteria to homeostasis disruption during intestinal inflammation. Life Sci 215(15):145–151. https://doi.org/10.1016/j.lfs.2018.11.009
  Article CAS PubMed Google Scholar
• Frasinariu OE, Ceccarelli S, Alisi A, Moraru E, Nobili V (2012) Gut-liver axis and fibrosis in nonalcoholic fatty liver disease: an input for novel therapies. Dig Liver Dis 45(7):543–551. https://doi.org/10.1016/j.dld.2012.11.010
  Article CAS PubMed Google Scholar
• Gangarapu V, Yıldız K, Ince AT, Baysal B (2014) Role of gut microbiota: obesity and NAFLD. Turk J Gastroenterol 25(2):133–140. https://doi.org/10.5152/tjg.2014.7886
  Article PubMed Google Scholar
• Gkolfakis P, Dimitriadis G, Triantafyllou K (2015) Gut microbiota and non-alcoholic fatty liver disease. Hepatobiliary Pancreat Dis Int 14(6):572–581. https://doi.org/10.1016/S1499-3872(15)60026-1
  Article PubMed Google Scholar
• Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Brummer RJ (2008) Review article: The role of butyrate on colonic function. Aliment Pharmacol Ther 27(2):104–119. https://doi.org/10.1111/j.1365-2036.2007.03562.x
  Article CAS PubMed Google Scholar
• Hosseini E, Grootaert C, Verstraete W, Wiele TVd (2011) Propionate as a health-promoting microbial metabolite in the human gut. Nutr Rev 69(5):245–258. https://doi.org/10.1111/j.1753-4887.2011.00388.x
• Hung SC, Tseng WT, Pan TM (2016) Lactobacillus paracasei subsp. paracasei NTU 101 ameliorates impaired glucose tolerance induced by a high-fat, high-fructose diet in Sprague-Dawley rats. J Funct Foods 24:472–481. https://doi.org/10.1016/j.jff.2016.04.033
  Article CAS Google Scholar
• Jobin C, Sartor RB (2000) The IκB/NF-κB system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol 278(3):C451–C462. https://doi.org/10.1152/ajpcell.2000.278.3.C451
  Article CAS PubMed Google Scholar
• Kim WG, Kim HI, Kwon EK, Han MJ, Kim DH (2018) Lactobacillus plantarum LC27 and Bifidobacterium longum LC67 mitigate alcoholic steatosis in mice by inhibiting LPS-mediated NF-κB activation through restoration of the disturbed gut microbiota. Food Funct 9:4255–4265. https://doi.org/10.1039/C8FO00252E
  Article CAS PubMed Google Scholar
• Leung C, Rivera L, Furness JB, Angus PW (2016) The role of the gut microbiota in NAFLD. Nat Rev Gastroenterol Hepatol 13(7):412–425. https://doi.org/10.1038/nrgastro.2016.85
  Article CAS PubMed Google Scholar
• Ley RE, Turnbaugh PJ, Klein S, Gordon JI (2006) Microbial ecology: human gut microbes associated with obesity. Nature 444(7122):1022–1023. https://doi.org/10.1038/nature4441022a
  Article CAS PubMed Google Scholar
• Li S, Li J, Mao G, Wu T, Hu Y, Ye X, Tian D, Linhardt RJ, Chen S (2018) A fucoidan from sea cucumber Pearsonothuria graeffei with well-repeated structure alleviates gut microbiota dysbiosis and metabolic syndromes in HFD-fed mice. Food Funct 9(10):5371–5380. https://doi.org/10.1039/C8FO01174E
  Article CAS PubMed Google Scholar
• Lim SM, Jeong JJ, Woo KH, Han MJ, Kim DH (2016) Lactobacillus sakei OK67 ameliorates high-fat diet-induced blood glucose intolerance and obesity in mice by inhibiting gut microbiota lipopolysaccharide production and inducing colon tight junction protein expression. Nutr Res 36(4):337–348. https://doi.org/10.1016/j.nutres.2015.12.001
  Article CAS PubMed Google Scholar
• Liu R, Hong J, Xu X, Feng Q, Zhang D, Gu Y, Shi J, Zhao S, Liu W, Wang X, Xia H, Liu Z, Cui B, Liang P, Xi L, Jin J, Ying X, Wang X, Zhao X, Li W, Jia H, Lan Z, Li F, Wang R, Sun Y, Yang M, Shen Y, Jie Z, Li J, Chen X, Zhong H, Xie H, Zhang Y, Gu W, Deng X, Shen B, Xu X, Yang H, Xu G, Bi Y, Lai S, Wang J, Qi L, Madsen L, Wang J, Ning G, Kristiansen K, Wang W (2017) Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med 23(7):859–868. https://doi.org/10.1038/nm.4358
  Article CAS PubMed Google Scholar
• Lu Y, Fan C, Li P, Lu Y, Chang X, Qi K (2016) Short chain fatty acids prevent high-fat-diet-induced obesity in mice by regulating G protein-coupled receptors and gut microbiota. Sci Rep 6:37589. https://doi.org/10.1038/srep37589
  Article CAS PubMed PubMed Central Google Scholar
• Mani S, Cao W, Wu L, Wang R (2014) Hydrogen sulfide and the liver. Nitric Oxide 41(18):62–71. https://doi.org/10.1016/j.niox.2014.02.006
  Article CAS PubMed Google Scholar
• Marra F, Svegliati-Baroni G (2018) Lipotoxicity and the gut-liver axis in NASH pathogenesis. J Hepatol 68(2):280–295. https://doi.org/10.1016/j.jhep.2017.11.014
  Article CAS PubMed Google Scholar
• Mujagic Z, de Vos P, Boekschoten MV, Govers C, Pieters HHM, de Wit NJW, Bron PA, Masclee AAM, Troost FJ (2017) The effects of Lactobacillus plantarum on small intestinal barrier function and mucosal gene transcription; a randomized double-blind placebo controlled trial. Sci Rep 7:40128. https://doi.org/10.1038/srep40128
  Article CAS PubMed PubMed Central Google Scholar
• Norusis M (2007) SPSS 15.0 advanced statistical procedures companion. Prentice Hall, Upper Saddle River
• Plaza-Diaz J, Gomez-Llorente C, Abadia-Molina F, Saez-Lara MJ, Campaña-Martin L, Muñoz-Quezada S, Romero F, Gil A, Fontana L (2014) Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats. PLoS One 9:e98401. https://doi.org/10.1371/journal.pone.0098401
  Article CAS PubMed PubMed Central Google Scholar
• Safari Z, Gérard P (2019) The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD). Cell Mol Life Sci 76(8):1541–1558. https://doi.org/10.1007/s00018-019-03011-w
  Article CAS PubMed Google Scholar
• Vajro P, Paolella G, Fasano A (2013) Microbiota and gut-liver axis: a mini-review on their influences on obesity and obesity related liver disease. J Pediatr Gastroenterol Nutr 56(5):461–468. https://doi.org/10.1097/MPG.0b013e318284abb5
  Article CAS PubMed PubMed Central Google Scholar
• van der Beek CM, Canfora EE, Lenaerts K, Troost FJ, Damink SWMO, Holst JJ, Masclee AAM, Dejong CHC, Blaak EE (2016) Distal, not proximal, colonic acetate infusions promote fat oxidation and improve metabolic markers in overweight/obese men. Clin Sci 130(22):2073–2082. https://doi.org/10.1042/cs20160263
  Article CAS Google Scholar
• Vanni E, Bugianesi E (2010) The gut-liver axis in nonalcoholic fatty liver disease: another pathway to insulin resistance? Hepatology 49(6):1790–1792. https://doi.org/10.1002/hep.23036
  Article CAS Google Scholar
• Wang FS, Fan JG, Zhang Z, Gao B, Wang HY (2014) The global burden of liver disease: the major impact of China. Hepatology 60(6):2099–2108. https://doi.org/10.1002/hep.27406
  Article PubMed Google Scholar
• Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius DM, Lu CC, Young JD, Lai HC (2018) Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68(2):248–262. https://doi.org/10.1136/gutjnl-2017-315458
  Article CAS PubMed Google Scholar
• Xue L, He J, Gao N, Lu X, Li M, Wu X, Liu Z, Jin Y, Liu J, Xu J, Geng Y (2017) Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemia. Sci Rep 7:45176. https://doi.org/10.1038/srep45176
  Article CAS PubMed PubMed Central Google Scholar
• Yang S, Yu M, Sun L, Xiao W, Yang X, Sun L, Zhang C, Ma Y, Yang H, Liu Y, Lu D, Teitelbaum DH, Yang H (2014) Interferon-γ-induced intestinal epithelial barrier dysfunction by NF-κB/HIF-1α pathway. J Interf Cytokine Res 34(3):195–203. https://doi.org/10.1089/jir.2013.0044
  Article CAS Google Scholar
• Zhao L, Jiang Y, Ni Y, Zhang T, Duan C, Huang C, Zhao Y, Gao L, Li S (2017) Protective effects of Lactobacillus plantarum C88 on chronic ethanol-induced liver injury in mice. J Funct Foods 35:97–104. https://doi.org/10.1016/j.jff.2017.05.017
  Article CAS Google Scholar
• Zhao Z, Wang C, Zhang L, Zhao Y, Duan C, Zhang X, Gao L, Li S (2019) Lactobacillus plantarum NA136 improves the non-alcoholic fatty liver disease by modulating the AMPK/Nrf2 pathway. Appl Microbiol Biotechnol 103(14):5843–5850. https://doi.org/10.1007/s00253-019-09703-4
  Article CAS PubMed Google Scholar

Download references